Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Fortress Biotech’s Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
-
AI Service Robotics Market Accelerates as Platforms Move from Prototype to Revenue Deployment
-
Ultragenyx Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application (BLA) for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
-
Satellogic Launches Aleph Observer, a Persistent Global Intelligence Capability Designed for Sustained Awareness at Scale
-
Off The Hook to Host Investor Webinar to Discuss APEX Acquisition Expected to Add $30M in Revenue and Deliver $3M in Annual Cost Savings
-
Healthcare REITs, Skilled Nursing Real Estate Gain Momentum Amid Aging Demographics and Stable Income Growth
-
NetworkNews Audio Announces Audio Press Release (APR) Discussing Growing Investor Attention on Companies Holding Clinical-Stage Portfolios
-
Bicara Therapeutics to Participate in Upcoming Investor Conferences
-
ICU Medical to Participate in Upcoming Investor Conferences
-
Blue Genes Partners with RxSense to Deliver Actionable PGx at the Point of Adjudication
-
ARKO Corp. Opens Newly Remodeled Apple Market with fas craves Food Concept in Hazard, KY
-
CISO Global Appoints Dhaval Damania as EVP of Cybersecurity & IT
-
Trident Resources Accelerates Winter Exploration Program with the Addition of a Third Drill Rig to the Contact Lake Gold Project in Northern Saskatchewan, Canada
-
FibroBiologics Granted Extension by Nasdaq to Regain Compliance
-
Wave Life Sciences to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
-
rYojbaba Announces Participation in the Guardian Girls Aikido Project in Los Angeles, CA
-
Plexus to Present at the Raymond James 47th Annual Institutional Investors Conference
-
K Wave Media Regains Compliance with Nasdaq Minimum Market Value Requirement
-
ToltIQ and Intapp Partner to Unify Deal Execution and Due Diligence for Private Markets Firms
-
Xanadu Nominates Experienced Global Business Leaders to its Board of Directors
-
Nexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders
-
Lead Real Estate Co., Ltd Announces Completion of NAOI STYLE NAKAMEGURO YUTENJI 1-CHOME Single-Family Home in Tokyo
-
Thirteen Industry Leaders Unite to Define Active Copper Cable Standards
-
Ocean Power Technologies Provides Operational Update on Global Deployments and Infrastructure Development
-
Compass Diversified Announces Appointment of Eric Weis as President of PrimaLoft; Elevation of Shawn Neville to PrimaLoft Board Chair
-
Transactions in connection with share buyback programme
-
Safe Pro Group Projects Over 500% Year-Over-Year Q1 2026 Revenue Growth Following U.S. Government Award for AI Edge Processing Systems
-
Johnson Fistel Investigates the Grindr Board for Potential Breaches of Fiduciary Duties Relating to the Grindr Buyout Termination
-
Celldex Announces Multiple Upcoming Presentations at AAAAI 2026 Supporting Barzolvolimab’s First-in-Class and Best-in-Disease Profile
-
CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference
-
Geron Plans to Present at Upcoming Investor Conferences
-
Beyond Oil Announces Meeting of Shareholders
-
FTC Solar Announces Supply Agreement with Lubanzi Inala
-
Axonius Federal Systems Names Jared Vichengrad Senior Vice President and General Manager Following Record Federal Results
-
Seismic Therapeutic to Participate in Upcoming Investor Conferences
-
Daré Bioscience Announces FDA Clearance of IND for Phase 2 Clinical Study of DARE-HPV, a Potential Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer
-
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on March 4
-
LifeMD to Report Fourth Quarter 2025 Financial Results on March 9
-
Beacon Therapeutics to Participate in TD Cowen's 46th Annual Health Care Conference
-
MBX Biosciences to Participate in Upcoming March Investor Conferences
-
BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day
-
Precise Bio Announces Successful Transplantation of Additional Patients in Ongoing Clinical Study of 3D-Bio-Printed Corneal Implant
-
MKS Inc. to Participate in Morgan Stanley’s Technology, Media & Telecom Conference
-
Leading Heart Transplant Centers Convene in Houston for Picard Medical/ SynCardia’s Total Artificial Heart Surgical Training
-
Pelthos Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
-
Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference
-
Lyell Immunopharma Announces Participation in March Investor Conferences
-
LYB announces updated 2030 sustainability goals
-
Corporate Debt and Equity CUSIP Request Volumes Increase in January
-
Ascentage Pharma to Participate in Three Upcoming Investor Conferences

